The Conversation (0)
SQI Diagnostics Inc. (TSXV:SQD), a Canadian life sciences company, announced that it has established a committee comprised of the company’s chairman and two independent directors in order to review possible strategic transactions, including a merger or sale of the company.
SQI Diagnostics Inc. (TSXV:SQD), a Canadian life sciences company, announced that it has established a committee comprised of the company’s chairman and two independent directors in order to review possible strategic transactions, including a merger or sale of the company.
As quoted in the press release:
The Company intends to continue to actively explore these and other alternatives, including strategic alliances. The Company’s research and development activities, regulatory processes related to its diagnostic product pipeline, commercial operations and business development activities including the growth of its Diagnostics Tools and Services business will continue during this process.
There can be no assurance that this process will result in any specific action or transaction. The Company does not undertake any obligation to update this information.
Click here to read the full SQI Diagnostics Inc. (TSXV:SQD) press release.